Dianicline
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(5aS,8S,10aR)-5a,6,9,10-Tetrahydro,7H,11H-8,10a-methanopyrido[2',3':5,6]pyrano[2,3-d]azepine
|
|
Identifiers | |
CAS Number | 292634-27-6 Y |
ATC code | none |
PubChem | CID 9816447 |
ChemSpider | 8352269 N |
UNII | Y0SNM34C6O Y |
ChEMBL | CHEMBL187927 N |
Chemical data | |
Formula | C13H16N2O |
Molar mass | 216.278 |
3D model (Jmol) | Interactive image |
|
|
|
|
NY (what is this?) (verify) |
Dianicline (SSR-591,813) is a drug developed by Sanofi-Aventis which acts as a partial agonist at neural nicotinic acetylcholine receptors. It is subtype-selective, binding primarily to the α4β2 subtype. It is being developed as a medication for the treatment of nicotine dependence to assist in smoking cessation.[1] Dianicline is very similar to the already marketed drug varenicline and it is unclear what advantages it will have over the older drug, although it may have an improved side effect profile. It has been through human trials up to Phase II, although results have not yet been reported. Drug development has been discontinued after reporting of unfavourable results during Phase III trials.[2][3][4]
References[edit]
- ^ Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrie P, Scatton B. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation. Journal of Pharmacology and Experimental Therapeutics. 2003 Jul;306(1):407-20. PMID 12682217
- ^ Fagerström K, Balfour DJK. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opinion on Investigational Drugs. 2006; 15(2):107-116.
- ^ Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation
- ^ Sanofi Pipeline
Treatment of drug dependence (N07B)
|
|
---|---|
Nicotine dependence | |
Alcohol dependence | |
Opioid dependence | |
Benzodiazepine dependence | |
Amphetamine dependence | |
Cocaine dependence |
Hidden categories:
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields